The FINANCIAL -- In large clinical trial conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With large numbers of COVID-19 patients requiring hospitalization, these outcomes could also help reduce the overload on intensive care units around the world.…
Read More »
The FINANCIAL -- In large clinical trial conducted worldwide, full dose anti-coagulation (blood thinner) treatments given to moderately ill patients hospitalized for COVID-19 reduced the requirement of vital organ support—such as the need for ventilation. A trend in possible reduction of mortality was also observed and is being further studied. With large numbers of COVID-19…
You might be interested in
WASHINGTON, D.C. — A recent Gallup poll finds that 14% of U.S. parents of children under age 5 say their…
The FINANCIAL — Fifty-three percent of six-year-olds met the recommended daily guidelines for moderate-to-vigorous physical activity in a study carried…
The FINANCIAL — New technology paves the way for individualised treatment plans for women.A UK start-up has developed an easy…
AUGUSTA, GA: A Rockdale County, Ga., nurse practitioner has been sentenced to federal prison and ordered to pay more than…